Asia Pacific Veterinary Healthcare Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Product, by Animal Type and Geography

Market Snapshot

Picture4 Asia Pacific Veterinary Healthcare Market
Study Period:

2016-2024

Base Year:

2018

CAGR:

10%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

Risk of emerging zoonosis is the major factor fuelling the growth of Asia Pacific Veterinary Healthcare Market. According to Ministry of Agriculture, Food and Rural Affairs (MAFRA), in 2016, the emergence of bird flu in South Korea made the government culled over 30 million chickens and ducks across the country as a preventive measure, therefore creating a shortage of eggs in the domestic market. Other factors that are responsible for the growth of the market are a rise in farm animals and growing technological advancements in animal healthcare. According to the National Dairy Development Board 2017, India has a cattle population of 156.7 million and it has one of the largest animal husbandry sectors in the world, along with the largest livestock population, with 520.6 million heads. However, the use of counterfeit medicines, lack of infrastructure and funding is restraining the growth of Asia-Pacific veterinary healthcare market.

Scope of the Report

As per the scope of this report, the AsiaPacific veterinary healthcare market comprises of therapeutic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canine, feline, and equine. Farm animals are bovine, poultry, and porcine.

By Product
By Therapeutics
Vaccines
Parasiticides
Anti-infectives
Medical Feed Additives
Other Therapeutics
By Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Other Animals
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Molecular Diagnostics are Expected to Lead the Market

The market for veterinary molecular diagnostics is expected to increase over the forecast period due to the uptrend in the academic research activity pertaining to veterinary molecular diagnostics and investigational techniques to target epidemic-like conditions in companion and farm animals. Apart from this, there is an increasing application of molecular diagnostic techniques in the identification of bacterial diseases, like Brucella, through enzyme-linked immunosorbent assay (ELISA), Rose Bengal Plate Test (RBPT), and PCR-based diagnosis. The department of veterinary medical sciences at the Graduate School of Agricultural and Life Sciences, University of Tokyo, is involved in conducting advanced research at molecular, cellular, and in vivo levels, in order to fully understand vital processes of normal and diseased animals. Overall, the market for veterinary molecular diagnostics in the Asia Pacific region is likely to register high growth over the forecast period. Though the market is in the nascent stage, there are tremendous opportunities for market growth, primarily due to increased activity in academic research and government funding.

Picture3 Asia Pacific Veterinary Healthcare Market

To understand key trends, Download Sample Report

Competitive Landscape

The market players in the Asia Pacific Veterinary Healthcare market are involved in various growth strategies such as collaborations, partnerships, agreements, mergers, and acquisitions in order to enhance the market presence. Major Players in Asia Pacific Veterinary Healthcare market are Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Inc., Elanco (Eli Lilly and Company), Merck Animal Health, Zoetis and Virbac Corporation, amongst others.

Major Players

  1. Merck Animal Health
  2. Vetoquinol
  3. Elanco
  4. Ceva Animal Health Inc
  5. Boehringer Ingelheim International GmbH

* Complete list of players covered available in the table of contents below

Picture2 Asia Pacific Veterinary Healthcare Market

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

      1. 4.1.1 Advanced Technology Leading to Innovations in Animal Healthcare

      2. 4.1.2 Increasing Productivity at the Risk of Emerging Zoonosis

    2. 4.2 Market Restraints

      1. 4.2.1 Increasing Cost of Animal Testing and Veterinary Services

      2. 4.2.2 Lack of Infrastructure and Funding

      3. 4.2.3 Use of Counterfeit Medicines

    3. 4.3 Porter's Five Force Analysis

      1. 4.3.1 Threat of New Entrants

      2. 4.3.2 Bargaining Power of Buyers/Consumers

      3. 4.3.3 Bargaining Power of Suppliers

      4. 4.3.4 Threat of Substitute Products

      5. 4.3.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. 5.1.1.1 Vaccines

        2. 5.1.1.2 Parasiticides

        3. 5.1.1.3 Anti-infectives

        4. 5.1.1.4 Medical Feed Additives

        5. 5.1.1.5 Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Immunodiagnostic Tests

        2. 5.1.2.2 Molecular Diagnostics

        3. 5.1.2.3 Diagnostic Imaging

        4. 5.1.2.4 Clinical Chemistry

        5. 5.1.2.5 Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Zoetis Inc.

      2. 6.1.2 Merck Animal Health

      3. 6.1.3 Vetoquinol

      4. 6.1.4 Elanco

      5. 6.1.5 Bayer Healthcare

      6. 6.1.6 Ceva Animal Health Inc.

      7. 6.1.7 Virbac

      8. 6.1.8 IDEXX Laboratories

      9. 6.1.9 Phibro Animal Health

      10. 6.1.10 Boehringer Ingelheim International GmbH

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information